Romiplostim Withdrawn Phase 3 Trials for Thrombocytopenia Chemotherapy Induced Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03343847Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.